March 26, 2020 / 9:37 PM / 9 days ago

BRIEF-Neubase Therapeutics Reports Q1 Loss Per Share Of $0.26

March 26 (Reuters) - NeuBase Therapeutics Inc:

* NEUBASE THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE FIRST FISCAL QUARTER OF 2020

* Q1 LOSS PER SHARE $0.26

* Q1 EARNINGS PER SHARE ESTIMATE $-0.32 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below